TheraRadar
← Back
Data updated: Mar 29, 2026

MERIDIAN BIOSCIENCE

Infectious DiseaseOncology
Pharma

MERIDIAN BIOSCIENCE is a pharmaceutical company focused on Infectious Disease, Oncology.

2002
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 83%
0 drugs Phase 3: 2 Phase 2: 1
Oncology 17%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease
Merck big-pharma
Oncology, Infectious Disease
Baxter specialty
Infectious Disease, Oncology
AbbVie big-pharma
Oncology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Infectious Disease